m+Medelevator.RU
← Поиск публикаций
Proceedings of the National Academy of Sciences of the United States of America · 2015

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

СтатьяМногоцентровое исследованиеResearch Support, N.I.H., IntramuralПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ombrello Michael J, Remmers Elaine F, Tachmazidou Ioanna, Grom Alexei, Foell Dirk, Haas Johannes-Peter, Martini Alberto, Gattorno Marco, Özen Seza, Prahalad Sampath, Zeft Andrew S, Bohnsack John F, Mellins Elizabeth D, Ilowite Norman T, Russo Ricardo, Len Claudio, Hilario Maria Odete E, Oliveira Sheila, Yeung Rae S M, Rosenberg Alan, Wedderburn Lucy R, Anton Jordi, Schwarz Tobias, Hinks Anne, Bilginer Yelda, Park Jane, Cobb Joanna, Satorius Colleen L, Han Buhm, Baskin Elizabeth, Signa Sara, Duerr Richard H, Achkar J P, Kamboh M Ilyas, Kaufman Kenneth M, Kottyan Leah C, Pinto Dalila, Scherer Stephen W, Alarcón-Riquelme Marta E, Docampo Elisa, Estivill Xavier, Gül Ahmet, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, de Bakker Paul I W, Raychaudhuri Soumya, Langefeld Carl D, Thompson Susan, Zeggini Eleftheria, Thomson Wendy, Kastner Daniel L, Woo Patricia, International Childhood Arthritis Genetics (INCHARGE) Consortium

Аннотация

Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P = 2.8 × 10(-17), odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P = 1.0 × 10(-5), OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed that HLA-DRB1*11 and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P = 2.7 × 10(-16), OR 2.3 (1.9, 2.8)], as was the HLA-DRB1*11-HLA-DQA1*05-HLA-DQB1*03 haplotype [6.4 × 10(-17), OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты